Literature DB >> 11069973

Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss.

P Mystkowski1, R J Seeley, T M Hahn, D G Baskin, P J Havel, A M Matsumoto, C W Wilkinson, K Peacock-Kinzig, K A Blake, M W Schwartz.   

Abstract

Melanin-concentrating hormone (MCH) is an orexigenic neuropeptide produced by neurons of the lateral hypothalamic area (LHA). Because genetic MCH deficiency induces hypophagia and loss of body fat, we hypothesized that MCH neurons may represent a specific LHA pathway that, when inhibited, contributes to the pathogenesis of certain anorexia syndromes. To test this hypothesis, we measured behavioral, hormonal, and hypothalamic neuropeptide responses in two models of hyperestrogenemia in male rats, a highly reproducible anorexia paradigm. Whereas estrogen-induced weight loss engaged multiple systems that normally favor recovery of lost weight, the expected increase of MCH mRNA expression induced by energy restriction was selectively and completely abolished. These findings identify MCH neurons as specific targets of estrogen action and suggest that inhibition of these neurons may contribute to the hypophagic effect of estrogen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069973      PMCID: PMC6773179     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  The physiology of motivation.

Authors:  E STELLAR
Journal:  Psychol Rev       Date:  1954-01       Impact factor: 8.934

Review 2.  Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; K R Feingold
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

3.  Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems.

Authors:  C Broberger; L De Lecea; J G Sutcliffe; T Hökfelt
Journal:  J Comp Neurol       Date:  1998-12-28       Impact factor: 3.215

4.  Glucagon-like peptide-1 and satiety.

Authors:  G van Dijk; T E Thiele; R J Seeley; S C Woods; I L Bernstein
Journal:  Nature       Date:  1997-01-16       Impact factor: 49.962

5.  Energy balance in ovariectomized rats with and without estrogen replacement.

Authors:  M L Laudenslager; C W Wilkinson; H J Carlisle; H T Hammel
Journal:  Am J Physiol       Date:  1980-05

Review 6.  Estrogen receptor null mice: what have we learned and where will they lead us?

Authors:  J F Couse; K S Korach
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

7.  Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

Authors:  J C Donahey; G van Dijk; S C Woods; R J Seeley
Journal:  Brain Res       Date:  1998-01-01       Impact factor: 3.252

8.  Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.

Authors:  M W Schwartz; R J Seeley; S C Woods; D S Weigle; L A Campfield; P Burn; D G Baskin
Journal:  Diabetes       Date:  1997-12       Impact factor: 9.461

9.  Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.

Authors:  P J Havel; T M Hahn; D K Sindelar; D G Baskin; M F Dallman; D S Weigle; M W Schwartz
Journal:  Diabetes       Date:  2000-02       Impact factor: 9.461

10.  Mice lacking melanin-concentrating hormone are hypophagic and lean.

Authors:  M Shimada; N A Tritos; B B Lowell; J S Flier; E Maratos-Flier
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

View more
  15 in total

1.  Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.

Authors:  Aska Hayashi; Masanori Suzuki; Masao Sasamata; Keiji Miyata
Journal:  Psychopharmacology (Berl)       Date:  2004-10-21       Impact factor: 4.530

2.  Oestradiol decreases melanin-concentrating hormone (MCH) and MCH receptor expression in the hypothalamus of female rats.

Authors:  J Santollo; L A Eckel
Journal:  J Neuroendocrinol       Date:  2013-06       Impact factor: 3.627

Review 3.  Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa.

Authors:  Rachel A Ross; Yael Mandelblat-Cerf; Anne M J Verstegen
Journal:  Harv Rev Psychiatry       Date:  2016 Nov/Dec       Impact factor: 3.732

Review 4.  Estrogens and Body Weight Regulation in Men.

Authors:  Katya B Rubinow
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 5.  Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms.

Authors:  T A Roepke
Journal:  J Neuroendocrinol       Date:  2008-12-06       Impact factor: 3.627

6.  Sex steroid-induced inhibition of food intake in sea bass (Dicentrarchus labrax).

Authors:  Esther Leal; Elisa Sánchez; Borja Muriach; José Miguel Cerdá-Reverter
Journal:  J Comp Physiol B       Date:  2008-08-16       Impact factor: 2.200

7.  Female mice and rats exhibit species-specific metabolic and behavioral responses to ovariectomy.

Authors:  Michelina Messina Witte; David Resuehr; Ashley R Chandler; Ashlee K Mehle; J Michael Overton
Journal:  Gen Comp Endocrinol       Date:  2010-01-11       Impact factor: 2.822

8.  Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice.

Authors:  A Gomori; A Ishihara; M Ito; H Matsushita; M Ito; S Mashiko; H Iwaasa; M Matsuda; M A Bednarek; S Qian; D J Macneil; A Kanatani
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

Review 9.  Perinatal exposure to endocrine disrupting compounds and the control of feeding behavior-An overview.

Authors:  Sabrina N Walley; Troy A Roepke
Journal:  Horm Behav       Date:  2017-11-07       Impact factor: 3.587

Review 10.  Electrophysiological effects of MCH on neurons in the hypothalamus.

Authors:  Xiao-Bing Gao
Journal:  Peptides       Date:  2009-05-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.